Pharma 4.0 & packaging at interpack 2020

By Melanie Streich Chronic diseases are more widespread than ever before. In industrial nations and, increasingly, in developing countries as well, they are among the most common and economically relevant health problems. The health sector’s global economic factor is accordingly high and simultaneously acts as leverage for the pharmaceutical industry, which invests a comparably high share of its revenue in research and development (R&D). In light of global demographic changes, the industry’s development opportunities are excellent. People are living longer and more health-conscious lives – which further increases the high-tech sector’s growth outlook. Growing drug development requirements result in a parallel increase in systems and machine technology demands in the field of packaging and bottling medicines.  “Today, pharmaceutical companies need integrated solutions. Machines provide the foundation for these. An extensive service offer and digital solutions, in particular, are gaining in importance,” explains Norbert Gruber, chairman – Executive Board at Uhlmann, which provides systems for packaging pharmaceuticals in blister packs, bottles, and boxes. The German family business, which has more than 2,300 employees around the world,…

Choose your subscription to read more